NASDAQ
2.01USD
-0.06 (-2.66%)
We have scored 3 news catalysts on Niagen Bioscience Inc (NAGE) over the past 12 months. The biggest single-day move next to one of them came Jul 16, 2026, when NAGE closed −2.0%: “Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research”. Coverage across the window leans mixed (average ticker sentiment +0.07).
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
159.2M
P/E
—
EPS
—
Beta
2.09
52W range
1.97-7.12
Day range
1.97–2.07
Open
2.07
Prev close
2.06
Volume
792.5K
Avg volume
567.9K
Dividend
0.00
IPO
2015-06-24
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Niagen Bioscience Inc — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for NAGE: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works